Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Increases By 700.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 800 shares, a growth of 700.0% from the June 30th total of 100 shares. Based on an average daily trading volume, of 16,000 shares, the days-to-cover ratio is currently 0.1 days.

Lexaria Bioscience Price Performance

LEXXW traded down $0.06 during midday trading on Thursday, reaching $1.02. The company’s stock had a trading volume of 1,472 shares, compared to its average volume of 15,988. Lexaria Bioscience has a 1 year low of $0.05 and a 1 year high of $2.50. The stock’s 50-day moving average is $1.19 and its 200-day moving average is $1.06.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.